COMP <GO>
PROF vs STIM // FREE CASH FLOW YIELD
Profound Medical Corp. (NASDAQ) VS. Neuronetics Inc. (NASDAQ) • 15-METRIC TALLY: PROF 3
— STIM 5
▲ FREE CASH FLOW YIELD LEADER: STIM
LAST: $5.86 (+1.38%) • MKT CAP: $214.1M
fcf-yield
-17.93%
LAST: $2.38 (+5.31%) • MKT CAP: $181.3M
fcf-yield
-11.25%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROF VS. STIM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PROF | STIM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.80% | 48.50% | +22.30 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -17.93% | -11.25% | -6.68 | STIM | /fcf-yield <GO> |
| Operating Margin | -60.00% | -21.10% | -38.90 | STIM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -26.10% | -33.90 | STIM | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | 99.20% | -33.90 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.97 | 0.20 | +5.77 | PROF | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.0 | 55.9 | -8.90 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $214.1M | $181.3M | $32.7M | PROF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PROF REV | STIM REV | PROF GROSS % | STIM GROSS % | PROF FCF | STIM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.1M | $149.2M | 70.8% | 48.5% | -$38.4M | -$20.4M |
| FY 2024 | $9.7M | $74.9M | 72.2% | 72.3% | -$23.5M | -$31.0M |
| FY 2023 | $5.9M | $71.3M | — | — | -$22.6M | -$32.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROF // BETA —
STIM // BETA —